Japanese Journal of Medical Technology
Online ISSN : 2188-5346
Print ISSN : 0915-8669
ISSN-L : 0915-8669
Technical Articles
Rapid detection of extended-spectrum β-lactamase-producing bacteria using DPS192iX
Saori KOBAYASHITatsuya NAKAMURAMari KUSUKIKenichiro OHNUMANobuhide HAYASHIGoh OHJIJun SAEGUSA
Author information
JOURNAL FREE ACCESS FULL-TEXT HTML

2017 Volume 66 Issue 6 Pages 649-655

Details
Abstract

Drug-resistant gram-negative bacilli have recently emerged as a major problem worldwide. The production of extended-spectrum β-lactamases (ESBLs) is an important resistance mechanism of pathogenic bacteria, which impedes the treatment of infections caused by gram-negative bacilli with drugs. Therefore, there is a compelling need to develop rapid detection methods for ESBL-producing bacteria. Herein, we evaluated the performance of a drug-susceptibility measurement instrument, DPS192iX (Eiken Chemical Co., Ltd.) for the rapid detection of ESBL-producing bacteria using various β-lactamase-producing Enterobacteriaceae strains. Seventy-one β-lactamase-producing strains were used for the analysis. The concordance between detection rates (within +/−1 difference in each tube) was >94% for all test agents compared with those obtained by the conventional method. The detection rates of 28 ESBL-producing strains were high: 96% for CTX, 68% for CAZ, 93% for CPR, and 96% for CPDX at 18 hours and 75% for CTX and 96% for CPDX at 5 hours. At 18 hours, all the ESBL-producing strains were detected using at least one of the agents. The results obtained should, however, be carefully examined because they depend on the genotypes of the ESBL-producing strains. Nevertheless, the drug susceptibilities of various β-lactamase-producing Enterobacteriaceae strains can be determined with high accuracy by using DPS192iX in routine tests. In addition, the ESBL-producing strains can be rapidly detected by using DPS192iX. In conclusion, the findings of this study demonstrate that the use of DPS192iX could ensure the proper use of antibiotics and thus contribute to the development of control measures against hospital infections caused by drug-resistant bacteria.

Content from these authors
© 2017 Japanese Association of Medical Technologists
Previous article Next article
feedback
Top